Mark Saad Overview

  • Primary Position
  • Board Member

  • Active Board Seats
  • 3

Mark Saad General Information

Biography

Mr. Mark Saad serves as Chief Executive Officer and Board Member at Nulids. He also serves as a Board Member of Axsome Therapeutics. He serves as a Partner at Alethea Capital Management. He serves as Board Member at Presidium Health. He previously served as the Chief Financial Officer of Bird Rock Bio. Prior to this, he served as the Chief Financial Officer of Cytori Therapeutics, where he was responsible for finance and accounting, business development, and other operating functions. Prior to Cytori, he served as Executive Director of UBS Investment Bank, where he was the COO of the Global Healthcare Group. Prior to UBS, Mr. Saad was part of the Health Care Investment Banking Group at Salomon Smith Barney. Mr. Saad holds a B.A. from Villanova University.

Contact Information

Primary Position
Board Member, Axsome Therapeutics
Education
Villanova University, BA (Bachelor of Arts)
Gender
Male
Phone
+1 (866)
Address
  • One World Trade Center
  • 22nd Floor
  • New York, NY 10007
  • United States
+1 (866)

Mark Saad Positions (2)

Firm name Firm type Title Location Industry Since
Alethea Capital Management Investor Partner San Diego, CA Venture Capital
NuLids Company Co-Chief Executive Officer & Board Member Escondido, CA Other Devices and Supplies

Mark Saad Board Seats (3)

Company Industry Ownership Status Financing Status Location Since
Axsome Therapeutics Biotechnology Publicly Held Corporation New York, NY
NuLids Other Devices and Supplies Privately Held (backing) Angel-Backed Escondido, CA
Presidium Health Clinics/Outpatient Services Privately Held (backing) Venture Capital-Backed San Diego, CA

Mark Saad Network (17)

Board Members (17)

Name Company Representing Location From
Ashkan Hayatdavoudi MD Presidium Health Presidium Health San Diego, CA
Amit Munshi Presidium Health Self San Diego, CA
Presidium Health Self San Diego, CA
Axsome Therapeutics Self New York, NY
Axsome Therapeutics Self New York, NY

Mark Saad FAQs

  • Who is Mark Saad?

    Mr. Mark Saad serves as Chief Executive Officer and Board Member at Nulids.

  • How much does Mark Saad typically invest?

    Mark Saad's median deal size is .

  • What is Mark Saad’s main position?

    Mark Saad’s primary position is Board Member.

  • How many active board seats does Mark Saad hold?

    Mark Saad holds 3 board seats including Axsome Therapeutics, NuLids, and Presidium Health.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »